微創醫療股票討論區

MicroPort Scientific's P/S ratio lags despite share price increase, possibly due to expected poor revenue growth. The company's underwhelming revenue outlook contributes to its low P/S, hindering a strong share price rise in the near future.

The company's growth in revenue has failed to deliver for shareholders, resulting in a total loss of 3% per year over the past five years.

Market expectations hint at continued slow revenue growth for MicroPort Scientific Corporation, reflecting in its suppressed P/S ratio and falling stock price. Its weaker revenue growth than the wider industry can explain its lower trading P/S ratio, possibly hindering future share price growth unless circumstances better.

Key points:
1. Hang Seng Index fell 2.57% in the first two weeks (2023/05/22 to 2023/06/02), with all 12 Hang Seng industries falling. Among them, the Hang Seng healthcare sector fell 1.51%, outperforming the Hang Seng Index by 1.06 percentage points, ranking third among the 12 Hang Seng industries
2. On May 22, the results of the f...